tiprankstipranks
Arctic Bioscience AS (DE:9TD)
STUTTGART:9TD
Germany Market
9TD
Arctic Bioscience AS
RESEARCH TOOLSreports

Arctic Bioscience AS (9TD) Financial Statements

1 Followers

Arctic Bioscience AS Financial Overview

Arctic Bioscience AS's market cap is currently €6.88M. The company's EPS TTM is €-1.9; its P/E ratio is -1.85; Arctic Bioscience AS is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 40.10Mkr 43.48Mkr 33.76Mkr 34.27Mkr 21.52M
Gross Profitkr -33.71Mkr 11.89Mkr 9.78Mkr 11.65Mkr 5.16M
Operating Incomekr -35.97Mkr -47.79Mkr -48.59Mkr -37.39Mkr 40.58M
EBITDAkr -33.12Mkr -39.63Mkr -43.20Mkr -30.29Mkr -37.94M
Net Incomekr -41.03Mkr -47.93Mkr -45.51Mkr -34.02Mkr -42.58M
Balance Sheet
Cash & Short-Term Investmentskr 1.29Mkr 2.16Mkr 79.60Mkr 144.15Mkr 227.36M
Total Assetskr 284.65Mkr 279.74Mkr 300.25Mkr 327.70Mkr 341.47M
Total Debtkr 62.32Mkr 32.86Mkr 2.05Mkr 1.10Mkr 4.18K
Net Debtkr 61.03Mkr 30.70Mkr -77.55Mkr -143.05Mkr -227.36M
Total Liabilitieskr 111.17Mkr 69.01Mkr 41.69Mkr 40.42Mkr 20.92M
Stockholders' Equitykr 173.49Mkr 210.73Mkr 258.56Mkr 287.28Mkr 320.55M
Cash Flow
Free Cash Flowkr -45.40Mkr -96.17Mkr -85.62Mkr -83.96Mkr -76.00M
Operating Cash Flowkr -22.65Mkr -45.36Mkr -40.29Mkr -25.40Mkr -39.49M
Investing Cash Flowkr -22.70Mkr -50.63Mkr -43.10Mkr -58.57Mkr -36.50M
Financing Cash Flowkr 43.36Mkr 19.66Mkr 18.84Mkr 749.99Kkr 290.76M
Currency in NOK

Arctic Bioscience AS Earnings and Revenue History

Income Statement >

Arctic Bioscience AS Debt to Assets

Balance Sheet >

Arctic Bioscience AS Cash Flow

Cash Flow >

Arctic Bioscience AS Forecast EPS vs Actual EPS

Earnings >